Grifols
Grifols Secures $21M MJFF Grant to Search for Early Parkinson's Biomarkers
Grifols subsidiary Alkahest will lead a pilot study to track proteomic changes in patient plasma samples over a 10-year period.
In a bid to expand recognition and treatment of alpha-1 antitrypsin deficiency, a cause of COPD, Grifols is making its over-the-counter genetic test available for free.